Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | KDM6B | O15054 | 1/20 | 0.33 |
| ▸ | KDM5C | P41229 | 1/20 | 0.33 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.33 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL662739 | 0.82 | LMNA (0.48) | LMNAALDH1A1HSD17B10TSHR | |
| SCHEMBL5907461 | 0.80 | LMNA (0.57) | LMNAALDH1A1HSD17B10 | |
| Acetone SCHEMBL590699 | 0.79 | LMNA (0.71) | LMNAALDH1A1HSD17B10TSHR | |
| Acetic Acid SCHEMBL23907968 | 0.77 | LMNA (0.67) | LMNAALDH1A1HSD17B10TSHR | |
| Acetic Acid SCHEMBL222953 | 0.77 | LMNA (0.67) | LMNAALDH1A1HSD17B10TSHR | |
| Butanedione SCHEMBL4368674 | 0.77 | LMNA (0.67) | LMNAALDH1A1HSD17B10TSHR | |
| Butane SCHEMBL3151311 | 0.77 | LMNA (0.52) | LMNAALDH1A1HSD17B10 | |
| SCHEMBL156391 | 0.76 | — | — | |
| SCHEMBL6055619 | 0.76 | LMNA (0.57) | LMNAALDH1A1HSD17B10TSHR | |
| Ethyl Acetate SCHEMBL9468886 | 0.76 | ALDH1A1 (0.67) | LMNAALDH1A1HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210085633-A1 | RIVASTIGMINE-CONTAINING TRANSDERMAL ABSORPTION PREPARATION | TEIKOKU SEIYAKU CO., LTD. (JP) | 2021-03-25 | — | — | US | disclosed |
| EP-3656383-A1 | RIVASTIGMINE-CONTAINING PERCUTANEOUS ABSORPTION-TYPE PREPARATION | Teikoku Seiyaku Co., Ltd. (JP) | 2020-05-27 | — | — | EP | disclosed |
| US-9468593-B2 | Oral composition | KABUSHIKI KAISHA SANGI (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20150202128-A1 | ORAL COMPOSITION | KABUSHIKI KAISHA SANGI (JP) | 2015-07-23 | — | — | US | disclosed |
| EP-2893918-A1 | ORAL COMPOSITION | Kabushiki Kaisha Sangi (JP) | 2015-07-15 | — | — | EP | disclosed |
| CN-101785863-B | Gel-forming composition | LINTEC CORP | 2013-06-05 | — | — | CN | disclosed |
| CN-1462194-B | Oral preparation and oral preparation holder | LINTEC CORP | 2013-04-24 | — | — | CN | disclosed |
| CN-101785863-A | Gel-forming composition | LINTEC CORP | 2010-07-28 | — | — | CN | disclosed |
| US-20040028724-A1 | Pharmaceutical preparation of percutaneous absorption type | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2004-02-12 | — | — | US | disclosed |
| CN-1462194-A | Oral preparation and oral preparation holder | LINTEC CORP (JP) | 2003-12-17 | — | — | CN | disclosed |
| EP-1340496-A1 | PHARMACEUTICAL PREPARATION OF PERCUTANEOUS ABSORPTION TYPE | HISAMITSU PHARMACEUTICAL CO. INC. (JP) | 2003-09-03 | — | — | EP | disclosed |